We are live on ! Find out more
PVAM

Pacific View Asset Management Portfolio holdings

AUM $20.8M
1-Year Est. Return 20.08%
This Fund
S&P 500
This Quarter Est. Return
-2.56%
1 Year Est. Return
+20.08%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$92.1M
AUM Growth
-$4.11M
Cap. Flow
-$36.3K
Cap. Flow %
-0.04%
Top 10 Hldgs %
52.17%
Holding
55
New
2
Increased
23
Reduced
20
Closed
5

Sector Composition

Rank Sector Weight
1 Industrials 23.04%
2 Financials 19.17%
3 Healthcare 16.6%
4 Consumer Staples 10.26%
5 Technology 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KIN
26
DELISTED
Kindred Biosciences, Inc.
KIN
$940K 1.02%
112,887
-69,075
-38% -$596K
QTS
27
DELISTED
QTS REALTY TRUST, INC.
QTS
$923K 1%
19,967
-148
-0.7% -$6.74K
RHP icon
28
Ryman Hospitality Properties
RHP
$8.4B
$920K 1%
11,370
-83
-0.7% -$6.79K
ADSW
29
DELISTED
Advanced Disposal Services Inc
ADSW
$917K 1%
28,730
-179
-0.6% -$5.63K
AVNT icon
30
Avient
AVNT
$3.45B
$896K 0.97%
28,517
+7,610
+36% +$213K
ALGT icon
31
Allegiant Air
ALGT
$2.64B
$891K 0.97%
6,204
WWD icon
32
Woodward
WWD
$25B
$856K 0.93%
7,573
-64
-0.8% -$6.86K
BCO icon
33
Brink's
BCO
$5.02B
$854K 0.93%
10,517
+5,069
+93% +$404K
ABM icon
34
ABM Industries
ABM
$2.8B
$791K 0.86%
19,759
-51,263
-72% -$1.95M
EGHT icon
35
8x8 Inc
EGHT
$247M
$740K 0.8%
30,654
-61,401
-67% -$1.43M
LPX icon
36
Louisiana-Pacific
LPX
$5.2B
$718K 0.78%
27,385
+14,193
+108% +$348K
ARRY
37
DELISTED
Array Biopharma Inc
ARRY
$666K 0.72%
14,364
-20,680
-59% -$581K
ZD icon
38
Ziff Davis
ZD
$1.9B
$661K 0.72%
8,562
+636
+8% +$48.1K
HCSG icon
39
Healthcare Services Group
HCSG
$1.56B
$660K 0.72%
+21,776
New +$720K
EME icon
40
Emcor
EME
$33.1B
$567K 0.62%
6,451
+1,645
+34% +$133K
BLD
41
DELISTED
TopBuild
BLD
$563K 0.61%
6,803
-52
-0.8% -$3.98K
IMMU
42
DELISTED
Immunomedics Inc
IMMU
$467K 0.51%
33,850
-30,909
-48% -$465K
BPMC
43
DELISTED
Blueprint Medicines
BPMC
$463K 0.5%
4,925
+1
+0% +$83
SUM
44
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$431K 0.47%
22,759
-86,399
-79% -$1.37M
KYNB
45
Kyntra Bio
KYNB
$28.5M
$429K 0.47%
380
+47
+14% +$51.4K
RARE icon
46
Ultragenyx Pharmaceutical
RARE
$2.65B
$394K 0.43%
6,216
+1,634
+36% +$104K
CBLK
47
DELISTED
Carbon Black, Inc. Common Stock
CBLK
$373K 0.4%
22,241
SLAB icon
48
Silicon Laboratories
SLAB
$7.15B
$359K 0.39%
3,488
+880
+34% +$84.9K
FOLD
49
DELISTED
Amicus Therapeutics
FOLD
$335K 0.36%
26,853
+1,496
+6% +$19K
SUPN icon
50
Supernus Pharmaceuticals
SUPN
$2.68B
$256K 0.28%
7,741
+533
+7% +$18.3K

Similar funds

Pacific View Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Pacific View Asset Management held 55 positions worth $92.1M, down 4.3% from $96.3M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pacific View Asset Management's Q2 2019 filing shows 2 new, 23 increased, 20 reduced and 5 closed positions. Its largest new stake was Zurn Elkay Water Solutions: 93,183 shares worth $1.36M. The largest sale was Sage Therapeutics, an estimated $4.78M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Pacific View Asset Management's largest Q2 2019 buy was Zurn Elkay Water Solutions: 93,183 shares worth $1.36M.
  • Pacific View Asset Management added most to PRA Health Sciences, Inc. in Q2 2019, an estimated $3.69M increase.
  • Pacific View Asset Management's biggest Q2 2019 reduction was Sage Therapeutics, cutting an estimated $4.78M.
  • Pacific View Asset Management fully exited Axsome Therapeutics in Q2 2019, selling an estimated $568K.
  • Pacific View Asset Management's ten largest holdings make up 52% of its $92.1M portfolio in Q2 2019.
  • Pacific View Asset Management opened 2 new positions and closed 5 in Q2 2019.
  • Pacific View Asset Management's portfolio value fell 4.3% quarter-over-quarter to $92.1M.

Based on Pacific View Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.